Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke R Bereznicki

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|July 3, 2018
Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, AustraliaGraeme Wertheimer, Luke R Bereznicki
European Journal of Clinical Pharmacology|September 24, 2017
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) studyEndalkachew Admassie, Leanne Chalmers, Luke R Bereznicki
Journal of Cardiovascular Pharmacology and Therapeutics|April 13, 2018
Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation StudyEndalkachew Admassie, Leanne Chalmers, Luke R Bereznicki
The American Journal of Cardiology|August 8, 2017
Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial FibrillationEndalkachew Admassie, Leanne Chalmers, Luke R Bereznicki
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 11, 2017
The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial FibrillationBridget Frain, Ronald Castelino, Luke R Bereznicki
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 11, 2016
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?Endalkachew A Alamneh, Leanne Chalmers, Luke R Bereznicki
Cardiovascular Therapeutics|February 9, 2017
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015Endalkachew Admassie Alamneh, Leanne Chalmers, Luke R Bereznicki
ANZ Journal of Surgery|September 20, 2012
Are the national orthopaedic thromboprophylaxis guidelines appropriate?Corinne Mirkazemi, Luke R Bereznicki, Gregory M Peterson
BMC Musculoskeletal Disorders|February 10, 2019
Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017Corinne Mirkazemi, Luke R Bereznicki, Gregory M Peterson
American Heart Journal|January 22, 2005
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEARShane L Jackson, Gregory M Peterson, Luke R Bereznicki
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Journal of Cardiovascular Pharmacology and Therapeutics|July 3, 2018
Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, AustraliaGraeme Wertheimer, Luke R Bereznicki
European Journal of Clinical Pharmacology|September 24, 2017
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) studyEndalkachew Admassie, Leanne Chalmers, Luke R Bereznicki
Journal of Cardiovascular Pharmacology and Therapeutics|April 13, 2018
Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation StudyEndalkachew Admassie, Leanne Chalmers, Luke R Bereznicki
The American Journal of Cardiology|August 8, 2017
Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial FibrillationEndalkachew Admassie, Leanne Chalmers, Luke R Bereznicki
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 11, 2017
The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial FibrillationBridget Frain, Ronald Castelino, Luke R Bereznicki
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 11, 2016
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?Endalkachew A Alamneh, Leanne Chalmers, Luke R Bereznicki
Cardiovascular Therapeutics|February 9, 2017
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015Endalkachew Admassie Alamneh, Leanne Chalmers, Luke R Bereznicki
ANZ Journal of Surgery|September 20, 2012
Are the national orthopaedic thromboprophylaxis guidelines appropriate?Corinne Mirkazemi, Luke R Bereznicki, Gregory M Peterson
BMC Musculoskeletal Disorders|February 10, 2019
Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017Corinne Mirkazemi, Luke R Bereznicki, Gregory M Peterson
American Heart Journal|January 22, 2005
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEARShane L Jackson, Gregory M Peterson, Luke R Bereznicki
Pageof 6